Related Experiment Video
Updated: May 3, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Pembrolizumab-Induced Anti-Yo-Antibody-Positive Cerebellitis: A Case Report
Takafumi Yamano1, Toshihide Yokoyama1, Tadashi Ishida1
1Department of Respiratory Medicine Kurashiki Central Hospital Okayama Japan.
Abstract:
We report a rare case of pembrolizumab-induced anti-Yo-antibody-positive cerebellitis in a patient with stage IV lung adenocarcinoma. Following two cycles of combination therapy, the patient developed nystagmus and ataxia. Despite tumour regression and normal magnetic resonance imaging (MRI) findings, cerebrospinal fluid analysis revealed lymphocyte-dominant hypercellularity, increased protein, and oligoclonal bands. Immune checkpoint inhibitor (ICI)-related cerebellitis was diagnosed after excluding infectious causes, metastases, and cancerous meningitis coupled with a positive anti-Yo antibody. Methylprednisolone pulse was ineffective, but high-dose intravenous immunoglobulin therapy resolved symptoms. To the best of our knowledge, this is the first case report of ICI-related cerebellitis with anti-Yo-antibody in lung adenocarcinoma. This case highlights the importance of paraneoplastic antibody testing in diagnosing ICI-related encephalitis, especially in cases of normal MRI findings.
More Related Videos
08:03Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
Published on: April 15, 2014
09:01Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Viral Meningitis
Arboviral Encephalitis
Cytomegalovirus Disease
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology